{
    "organizations": [],
    "uuid": "e1d2dd2f79ceec5a0f01da73d32cf623a466c27d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-astrazeneca-says-us-fda-approved-l/brief-astrazeneca-says-u-s-fda-approved-lokelma-in-u-s-for-treatment-of-adults-with-hyperkalaemia-idUSFWN1SP0VN",
    "ord_in_thread": 0,
    "title": "BRIEF-Astrazeneca Says U.S. FDA Approved Lokelma In U.S. For Treatment Of Adults With Hyperkalaemia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - AstraZeneca PLC:\n* ASTRAZENECA SAYS U.S. FDA APPROVED LOKELMA IN THE U.S. FOR THE TREATMENT OF ADULTS WITH HYPERKALAEMIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-19T05:42:00.000+03:00",
    "crawled": "2018-05-19T15:11:37.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "astrazeneca",
        "plc",
        "astrazeneca",
        "say",
        "fda",
        "approved",
        "lokelma",
        "treatment",
        "adult",
        "hyperkalaemia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}